Scientists from Creative Biolabs have successfully built up a unique platform to develop high-affinity bovine monoclonal antibodies with ultralong CDR3s.
Scientists from Creative Biolabs have successfully built up a unique platform to develop high-affinity bovine monoclonal antibodies with ultralong CDR3s.